Rebecca Weil
Corporate Officer/Principal presso OCULIS HOLDING AG
Posizioni attive di Rebecca Weil
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OCULIS HOLDING AG | Corporate Officer/Principal | 11/09/2023 | - |
Storia della carriera di Rebecca Weil
Precedenti posizioni note di Rebecca Weil
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IDORSIA LTD | Vendite & Marketing | 01/07/2019 | 01/08/2023 |
| SHIRE | Corporate Officer/Principal | 01/08/2016 | 01/03/2019 |
| Juvenile Diabetes Research Foundation (New York) | Direttore/Membro del Consiglio | - | - |
| BAUSCH + LOMB CORPORATION | Vendite & Marketing | - | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
| ALCON INC. | Corporate Officer/Principal | - | - |
Formazione di Rebecca Weil
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 5 |
| Stati Uniti | 4 |
| Irlanda | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 7 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| OCULIS HOLDING AG | Health Technology |
| IDORSIA LTD | Health Technology |
| ALCON INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| BAUSCH + LOMB CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Juvenile Diabetes Research Foundation (New York) |
- Borsa valori
- Insiders
- Rebecca Weil
- Esperienza
